Federal Submissions Raise ADA Concerns & Patient Safety at CenterWell Clinics

LAS VEGAS - April 13, 2026 - PRLog -- Submissions were sent on April 12, 2026, to the U.S. Department of Justice and the Centers for Medicare & Medicaid Services regarding access, accommodation, and patient safety concerns at CenterWell Las Vegas clinics and potentially CenterWell Corporate wide.

Concerns involve patients with environmental injury/chemical sensitivity (EI/CS), including fragrance, pesticides and airborne chemical exposure reactions that can cause immediate and severe symptom escalation in clinical environments lacking proper environmental controls.

Reports state patients should not have exacerbations inside healthcare facilities due to environmental exposure, lack of air quality control, or failure to recognize or accommodate chemical triggers, by CenterWell's medical personnel.

Patients report being required to establish an ongoing primary care physician relationship within the clinic system in order to receive care, including with physicians trained only in family medicine without EI/CS training. Patients report they are not permitted to receive limited or single-issue visits without being placed into a broader clinic-controlled care relationship.

These concerns include patient safety risks such as symptom escalation, misinterpretation of EI/CS reactions as unrelated medical conditions, delayed evaluation, or inappropriate treatment decisions when environmental triggers are not recognized.

EI/CS research shows that it is affecting up to approximately 30% of the population to varying degrees. Some to the point of complete disability and inability to leave their homes.

Concerns also include reported lack of staff and provider training regarding environmental exposures, including pesticide toxicity and chemical exposure risks in clinical environments.

Reports further state that pest control spraying occurs in clinic environments during patient presence or operational hours, raising concerns about airborne chemical exposure in occupied healthcare settings. One concern included the use of a pest control substance in a clinic environment where product MSDS warned not to use as an insecticide.

The submissions reference: Centers for Disease Control and Prevention, American Medical Association fragrance-free initiative.

Seniors remain a vulnerable population with high rates of respiratory conditions including asthma and COPD, increasing susceptibility to environmental exposure reactions, that CenterWell refuses to mitigate.

The submissions request formal CMS/Medicare oversight investigation into provider training limitations, EI/CS accommodation practices, environmental safety protocols, and clinic operational practices affecting patient access and safety.

ADA accommodations needed to be requested, if CenterWell's medical personnel actually had the most rudimentary training in EI/CS or toxicology accommodations wouldn't be needed.

Why are they 'Cherry Picking' what the AMA has now determined is a health hazard?

https://national-toxic-encephalopathy-foundation.org/#